PeptideDB

Ligelizumab

CAS No.: 1322627-61-1

Ligelizumab (QGE 031), a high-affinity humanized monoclonal anti-IgE antibody, is utilized in the research of chronic sp
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Ligelizumab (QGE 031), a high-affinity humanized monoclonal anti-IgE antibody, is utilized in the research of chronic spontaneous urticaria [1].
Synonyms QGE 031, Anti-IGHE Recombinant Antibody
molecular weight N/A
CAS 1322627-61-1
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 years